Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity: Outcome of 134 patients

Strahlentherapie und Onkologie

Volumn 184, Issue 1, 2008, Pages 23-29

  Eich, Hans Theodor ^a   Löschcke, Michael ^a   Scheer, Martin ^a   Kocher, Martin ^a   Bongartz, Rudolf ^a   Wacker, Sidonie ^a   Zöller, Joachim E ^a   Müller, Rolf Peter ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Carboplatin; Neoadjuvant; Oral carcinoma; Preoperative; Radiochemotherapy

Indexed keywords

CARBOPLATIN;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; ENTERIC FEEDING; ERYTHEMA; FEEDING APPARATUS; FEMALE; FISTULA; HUMAN; MAJOR CLINICAL STUDY; MALE; MANDIBLE; MOUTH CARCINOMA; MUCOSA INFLAMMATION; NECK DISSECTION; POSTOPERATIVE COMPLICATION; PROGNOSIS; RADIATION NECROSIS; REOPERATION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; TREATMENT OUTCOME; WOUND HEALING IMPAIRMENT; XEROSTOMIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NECK DISSECTION; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES;

EID: 38149116265     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-008-1725-6     Document Type: Article

References (43)

1. Bootz F, Howaldt HP, Mergenthaler HG, et al. Carcinoma of the upper aerodigestivtract. In: AWMF online - standard of care in oncology http://www.uni-duesseldorf.de/AWMF/ll/ll_032.htm. Düsseldorf: Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), 2003.
2. Braun OM, Neumeister B, Neuhold N, et al. Histological grading of therapy induced regression in squamous cell carcinomas of the oral cavity. A morphological and immunohistochemical study. Pathol Res Pract 1989;185:368-72.
3. Brizel DM, Sibley GS, Prosnitz LR, et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1997;38:285-9.
4. Cox DR. Regression models and life tables (with discussion). J R Stat Soc 1972;B34:187-202.
5. Dietz A, Rudat V, Conradt C, et al. Prognostic value of hemoglobin level for primary radiochemotherapy of head-neck carcinomas. HNO 2000;48:655-64.
6. Dobrowsky W, Dobrowsky E, Strassl H et al. Response to preoperative concomitant radiochemotherapy with mitomycin C and 5-fluorouracil in advanced head and neck cancer. Eur J Cancer Clin Oncol 1989;25:845-9.
7. Douple EB, Richmond RC, O'Hara JA et al. Carboplatin as a potentiator of radiation therapy. Cancer Treat Rev 1985;12:111-24.
8. Eckardt A, Rades D, Rudat V, et al. Prospective phase II study of neoadjuvant radiochemotherapy in advanced operable carcinoma of the mouth cavity. 3-year outcome. Mund Kiefer GesichtsChir 2002;6:117-21.
9. Giralt JL, Gonzalez J, del Campo JM, et al. Preoperative induction chemotherapy followed by concurrent chemoradiotherapy in advanced carcinoma of the oral cavity and oropharynx. Cancer 2000;89:939-45.
10. Glicksman AS, Slotman G, Doolittle C, et al. Concurrent cis-platinum and radiation with or without surgery for advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1994;30:1043-50.
11. Güner S, Staar S, Eich HT, et al. Randomized phase-II-study: neoadjuvant radiochemotherapy versus neoadjuvant radiotherapy for advanced squamous cell carcinoma of the oral cavity. Strahlenther Onkol 2001;177:Suppl 1:71.
12. Herrmann T, Knorr A, Dörner K. The RTOG/EORTC classification criteria for early and late radiation reactions. Radiobiol Radiother 1987;28:519-28.
13. Hoeller U, Biertz I, Flinzberg S, et al. Hyperfractionated-accelerated radiotherapy followed by radical surgery in locally advanced tumors of the oral cavity. Strahlenther Onkol 2006;182:157-63.
14. Howaldt HP, Vorast H, Blecher JC, et al. Results of the DOSAK tumor register. Mund Kiefer GesichtsChir 2000;4:216-25.
15. Kaplan EL, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-81.
16. Katayama A, Nonaka S, Bandoh N, et al. Evaluation of preoperative simultaneous radiochemotherapy combined with carboplatin and tegafur.uracil. Gan To Kagaku Ryoho 2002;29:873-9.
17. Kessler P, Grabenbauer G, Leher A, et al. Patients with oral squamous cell carcinoma. Long-term survival and evaluation of quality of life - initial results obtained with two treatment protocols in a prospective study. Mund Kiefer GesichtsChir 2004;8:302-10.
18. Kessler P, Grabenbauer G, Leher A, et al. Long-term survival of patients with primary oral squamous cell carcinoma. Comparison of two treatment protocols in a prospective study. Strahlenther Onkol 2007;183:184-9.
19. Kirita T, Ohgi K, Shimooka H, et al. Preoperative concurrent chemoradiotherapy plus radical surgery for advanced squamous cell carcinoma of the oral cavity: an analysis of long-term results. Oral Oncol 1999;35:597-606.
20. Klug C, Wutzl A, Kermer C, et al. Preoperative radiochemotherapy and radical resection for stages II-IV oral and oropharyngeal cancer: outcome of 222 patients. Int J Oral Maxillofac Surg 2005;34:143-8.
21. Klug C, Wutzl A, Kermer C, et al. Preoperative radiochemotherapy and radical resection for stages II-IV oral and oropharyngeal cancer: grade of regression as crucial prognostic factor. Int J Oral Maxillofac Surg 2005;34:262-7.
22. Knöbber D, Sack H, Stützer H, et al. Pre-irradiation and surgery of patients with squamous cell carcinoma of the oral cavity and oropharynx: the results of a 1973-1984 study. Strahlenther Onkol 1987;163:706-13.
23. Kuhnt T, Jirsak N, Muller AC, et al. Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer. Strahlenther Onkol 2005;181:520-8.
24. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
25. Mohr C, Bohndorf W, Carstens J, et al Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric randomized DÖSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up). Int J Oral Maxillofac Surg 1994;23:140-8.
26. Müller RP, Staar S, Samek M, Pape HD. Simultaneous preoperative radiochemotherapy with cisplatin in advanced oral cavity carcinoma: acute response and follow-up. In: Pape HD, Ganzer U, Schmitt G, eds. Recent results in cancer research. Berlin-Heidelberg-New York: Springer, 1994:165-72.
27. Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1996;41:31-9.
28. Panje WR, Namon AJ, Vokes E, et al. Surgical management of the head and neck cancer patient following concomitant multimodality therapy. Laryngoscope 1995;105:97-101.
29. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-41.
30. Perez CA, Brady LW. Acute radiation morbidity scoring criteria (RTOG). In: Perez CA, Brady LW, eds. Principles and practice of radiation oncology, 2nd edn. Philadelphia: Lippincott, 1993:51-3.
31. Perez CA, Brady LW. Acute radiation morbidity scoring criteria (RTOG). In: Perez CA, Brady LW, eds. Principles and practice of radiation oncology, 2nd edn. Philadelphia: Lippincott, 1993:53-5.
32. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 2000;355:949-55.
33. Rinehart J, Ruff T, Cheung A, et al. Neoadjuvant and concomitant chemotherapy and radiation therapy in patients with advanced head and neck carcinoma. Otolaryngol Head Neck Surg 2005;132:69-74.
34. Schultze J, Schillmöller H, Roldán JC, et al. Preoperative radiochemotherapy for advanced oral cavity tumors: the Kiel DOSAK experience regarding curability and quality of life. Mund Kiefer GesichtsChir 2006;10:249-57.
35. Seegenschmiedt MH, Sauer R. The systematics of acute and chronic radiation sequelae. Strahlenther Onkol 1993;169:83-95.
36. Skov K, MacPhail S. Interaction of platinum drugs with clinically relevant x-ray doses in mammalian cells: a comparison of cisplatin, carboplatin, iproplatin, and tetraplatin. Int J Radiat Oncol Biol Phys 1991;20:221-5.
37. Strnad V, Melzner W, Geiger M, et al. Role of interstitial PDR brachytherapy in the treatment of oral and oropharyngeal cancer. A single-institute experience of 236 patients. Strahlenther Onkol 2005;181:762-7.
38. Studer G, Studer SP, Zwahlen RA, et al. Osteoradionecrosis of the mandible: minimized risk profile following intensity-modulated radiation therapy (IMRT). Strahlenther Onkol 2006;182:283-8.
39. Union Internationale Contre le Cancer. Wittekind C, Klimpfinger M, Sobin LH, eds. TNM Atlas, 5th edn. Berlin-Heidelberg-New York: Springer, 2004:5-38.
40. Vaupel P, Mayer A, Hockel M. Impact of hemoglobin levels on tumor oxygenation: the higher, the better? Strahlenther Onkol 2006;182:63-71.
41. Wanebo H, Chougule P, Ready N, et al. Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV). Ann Surg Oncol 2001;8:644-50.
42. Weijers M, Snow GB, Bezemer DP, et al. The status of the deep surgical margins in tongue and floor of mouth squamous cell carcinoma and risk of local recurrence; an analysis of 68 patients. Int J Oral Maxillofac Surg 2004;33:146-9.
43. Zamboglou N, Pape H, Schnabel T, et al. Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors. Strahlenther Onkol 1989;165:647-51.